Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Withdrawn 3Recruiting 3Terminated 2Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Hepatoblastoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Tissue Banks × Clear all
NCT00298064 2023-07-05

Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer

University of New Mexico

Phase NA Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT01302002 2016-02-23

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Instituto Nacional de Cancer, Brazil

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Neoplasms

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Emory University

Phase NA Withdrawn
Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡